Clinical Trial Update: Phase1, Placebo-Controlled, Randomized, Double-blind, Single-ascending Dose Study in Healthy Subjects. [Phase 1]

View source ↗

Summary

Phase 1, placebo-controlled, randomized, double-blind, single-ascending-dose trial in healthy subjects for asthma sponsored by SolAeroMed Inc. has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: SolAeroMed Inc. | Conditions: Asthma | Phase 1 | Status: COMPLETED